Molecular-based imaging provides new opportunities to assess vital cellular processes in vivo. The ability tomonitor the molecular processes of cancer via non-invasive imaging may provide critical informationregarding the effects of therapy. In the context of pre-clinical research, the use of in vivo imaging permits theacquisition of a complete dynamic biodistribution study in each animal, thereby reducing the number ofanimals required to reach a statistically adequate result; often the techniques used in small animal imagingare directly transferable to the clinical setting. The Small Animal Imaging Core (SAIC) is a new sharedresource dedicated to providing investigators access to the state-of-the-art in small animal imagingcapabilities for use in basic and translational research relevant to the mission of the City of Hope CancerCenter.
Specific aims of the SAIC include: (1) maintaining a thorough understanding of the currentcapabilities and limitations of small animal imaging as they pertain to cancer research; (2) implementing,developing, calibrating, maintaining, and operating relevant imaging systems within the context of a smallanimal imaging laboratory; and (3) optimizing the use of small animal imaging in research at City of Hope byconsulting with investigators. Core personnel currently include a Director, an imaging physicist, and amanager, all of whom are highly experienced in the use of imaging for research with animals. Small animalimaging systems in operation include two units for bioluminescence optical imaging (I VIS 100, XenogenCorp.); a gamma camera (Y IMAGER, Biospace, Inc.); a PET scanner (microPET R4, CTIMI, Inc.); and a CTscanner (microCAT II Hi Res, CTIMI, Inc.). The microPET and microCAT are readily used in tandem togenerate co-registered functional-anatomic PET/CT images. The Animal Resources Center has providedfour rooms within the Parvin Biomedical Research Building for use by the animal imaging program (one roomfor the microPET, microCAT, and the y-IMAGER; two rooms for the Xenogen MS machines; and one roomfor a gamma counter). A system has been developed for billing users for a portion of the costs of the imagingprocedures. During the first 12-month reporting period, the SAIC was used by 13 Cancer Center membersfrom 3 Research Programs and peer-reviewed usage represented 89% of total usage. Annual budget for thecore is $165,922 (97% institution, 3% chargebacks); 42% ($70,000) is being requested from the CCSG.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA033572-25
Application #
7714127
Study Section
Subcommittee G - Education (NCI)
Project Start
2008-09-01
Project End
2012-11-30
Budget Start
2008-09-01
Budget End
2008-11-30
Support Year
25
Fiscal Year
2008
Total Cost
$49,650
Indirect Cost
Name
City of Hope/Beckman Research Institute
Department
Type
DUNS #
027176833
City
Duarte
State
CA
Country
United States
Zip Code
91010
Gong, Jun; Salgia, Ravi (2018) Managing Patients With Relapsed Small-Cell Lung Cancer. J Oncol Pract 14:359-366
Chen, Robert W; Palmer, Joycelynne M; Tomassetti, Sarah et al. (2018) Multi-center phase II trial of bortezomib and rituximab maintenance combination therapy in patients with mantle cell lymphoma after consolidative autologous stem cell transplantation. J Hematol Oncol 11:87
Romsdahl, Jillian; Blachowicz, Adriana; Chiang, Abby J et al. (2018) Characterization of Aspergillus niger Isolated from the International Space Station. mSystems 3:
Sen, Subha; He, Zhiheng; Ghosh, Shubhamoy et al. (2018) PRMT1 Plays a Critical Role in Th17 Differentiation by Regulating Reciprocal Recruitment of STAT3 and STAT5. J Immunol 201:440-450
Lueschow, Shiloh R; Stumphy, Jessica; Gong, Huiyu et al. (2018) Loss of murine Paneth cell function alters the immature intestinal microbiome and mimics changes seen in neonatal necrotizing enterocolitis. PLoS One 13:e0204967
Gu, Long; Lingeman, Robert; Yakushijin, Fumiko et al. (2018) The Anticancer Activity of a First-in-class Small-molecule Targeting PCNA. Clin Cancer Res 24:6053-6065
Zhao, Xingli; Zhang, Zhuoran; Moreira, Dayson et al. (2018) B Cell Lymphoma Immunotherapy Using TLR9-Targeted Oligonucleotide STAT3 Inhibitors. Mol Ther 26:695-707
Weitzel, Jeffrey N; Chao, Elizabeth C; Nehoray, Bita et al. (2018) Somatic TP53 variants frequently confound germ-line testing results. Genet Med 20:809-816
Ghose, Jayeeta; Viola, Domenico; Terrazas, Cesar et al. (2018) Daratumumab induces CD38 internalization and impairs myeloma cell adhesion. Oncoimmunology 7:e1486948
Aslamy, Arianne; Oh, Eunjin; Olson, Erika M et al. (2018) Doc2b Protects ?-Cells Against Inflammatory Damage and Enhances Function. Diabetes 67:1332-1344

Showing the most recent 10 out of 1396 publications